Search
Search Results
-
Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis
The evidence for the treatment of connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) mostly depends on subgroup or post...
-
Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
IntroductionPulmonary hypertension (PH) is often complicated by chronic lung diseases (CLDs) such as chronic obstructive pulmonary disease (COPD) and...
-
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype
AimTo obtain real-world evidence about the features and risk stratification of pulmonary arterial hypertension (PAH) with a left heart disease (LHD)...
-
Noninvasive assessment of pulmonary hypertension: key insights to maximize chest computed tomography
According to the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines, a right heart catheterization-derived mean...
-
Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
ObjectiveConnective tissue disease associated pulmonary hypertension (CTD-PH) is classified as a subgroup of WHO group 1 PH, also called pulmonary...
-
Cardiovascular metrics on CT pulmonary angiography in patients with pulmonary hypertension — re-evaluation under the updated guidelines of pulmonary hypertension
PurposeTo re-assess cardiovascular metrics on computed tomography pulmonary angiography (CTPA) in predicting pulmonary hypertension (PH) under the...
-
Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
BackgroundEmerging evidences have demonstrated that gut microbiota composition is associated with pulmonary arterial hypertension (PAH). However, the...
-
Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
BackgroundThe early and long-term outcomes after pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) have been...
-
Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension—The Right Ventricle as a Therapeutic Target to Improve Renal Function
Cardiorenal syndrome (CRS) due to right ventricular (RV) failure is a disease entity emerging as a key indicator of morbidity and mortality. The...
-
Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome
BackgroundObstructive sleep apnea–hypopnea syndrome is the most common form of SRBDs. Recurrent hypoxia, which accompanies OSAHS, increases the...
-
Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical conditions and complicate most systemic diseases....
-
Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction
BackgroundUp-regulation of ceramides in pulmonary hypertension (PH), contributing to perturbations in sphingolipid homeostasis and the transition of...
-
Anesthetic management of a patient with methamphetamine-associated pulmonary arterial hypertension undergoing laparoscopic cholecystectomy
BackgroundMethamphetamine abuse is a serious public health concern and causes various life-threatening disorders including pulmonary arterial...
-
Total pulmonary arterial reconstruction in a patient with arterial tortuosity syndrome affecting the pulmonary artery: a case report and review of the literature
BackgroundArterial tortuosity syndrome is a rare Autosomal recessive disease that leads to a loss of function of the connective tissues of the body,...
-
Arterial hypertension in infants with congenital diaphragmatic hernia following surgical repair
Pulmonary hypertension (PH) and cardiac dysfunction are established comorbidities of congenital diaphragmatic hernia (CDH). However, there is very...
-
Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension
IntroductionUS claims-based analyses emphasize the substantial hospitalization burden of patients with pulmonary arterial hypertension (PAH) and the...
-
Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics
BackgroundPulmonary arterial hypertension is a common complication in patients with congenital heart disease. In the absence of early diagnosis and...
-
Why Living with Pulmonary Arterial Hypertension Requires a Holistic Approach: A Patient and Clinician Perspective
Pulmonary arterial hypertension (PAH) is a rare disease caused by high pressure in the blood vessels leading from the heart to the lung. PAH affects...
-
Pulmonary artery imaging with 68 Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension
BackgroundThe feasibility and significance of imaging pulmonary artery (PA) remodeling with 68 Ga-fibroblast activating protein inhibitor (FAPI) in...
-
Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking
Pulmonary arterial hypertension (PAH) is a common complication of systemic lupus erythematosus (SLE), and PAH can cause right ventricle (RV) remodel...
